Kansas City Life Insurance Company (KCLI)
| Previous close | 35.35 |
| Open | 35.35 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 35.35 - 35.35 |
| 52-week range | 20.00 - 39.01 |
| Volume | |
| Avg. volume | 1,053 |
| Market cap | 342.309M |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | 6.23 |
| EPS (TTM) | 5.67 |
| Earnings date | 26 Apr 2024 - 30 Apr 2024 |
| Forward dividend & yield | 0.56 (1.58%) |
| Ex-dividend date | 01 May 2024 |
| 1y target est | N/A |
PR NewswireKansas City Life Announces Fourth Quarter 2023 Results
Kansas City Life Insurance Company recorded net income of $49.1 million or $5.07 per share in the fourth quarter of 2023, compared to a net loss of $17.3 million or $1.79 per share in the fourth quarter of 2022. The largest factor in this improvement was a $61.7 million increase in realized investment gains, largely due to real estate sales that generated a net pretax gain of $63.9 million in the fourth quarter of 2023. In addition, net investment income increased $1.8 million and operating expe
- PR Newswire
Kansas City Life Announces Sale of Real Estate
Kansas City Life Insurance Company (the "Company") has completed the sale of a certain real estate asset effective December 13, 2023.
- PR Newswire
Kansas City Life Announces Third Quarter 2023 Results
Kansas City Life Insurance Company recorded net income of $4.6 million or $0.47 per share in the third quarter of 2023 compared to net income of $4.3 million or $0.45 per share in the third quarter of 2022. Net income totaled $5.8 million or $0.60 per share in the first nine months of 2023, up from $1.1 million or $0.12 per share in the first nine months of 2022.
